Smith Chas P & Associates Pa Cpas Abbott Laboratories Transaction History

Smith Chas P & Associates Pa Cpas

  • $1.78 Billion
  • Q2 2025

A detailed history of Smith Chas P & Associates Pa Cpas transactions in Abbott Laboratories stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 5,483 shares of ABT stock, worth $693,818. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,483
Previous 7,650 28.33%
Holding current value
$693,818
Previous $1.01 Million 26.53%
% of portfolio
0.04%
Previous 0.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025
SELL
$123.95 - $138.08 $268,599 - $299,219
-2,167 Reduced 28.33%
5,483 $745,000
Q1 2025

May 08, 2025
SELL
$111.1 - $140.22 $77,770 - $98,154
-700 Reduced 8.38%
7,650 $1.01 Million
Q4 2024

Jan 21, 2025
SELL
$111.93 - $119.39 $6,715 - $7,163
-60 Reduced 0.71%
8,350 $944,000
Q3 2024

Oct 11, 2024
SELL
$100.07 - $118.13 $7,805 - $9,214
-78 Reduced 0.92%
8,410 $958,000
Q2 2024

Jul 29, 2024
SELL
$100.73 - $112.44 $3,525 - $3,935
-35 Reduced 0.41%
8,488 $881,000
Q1 2024

Apr 25, 2024
SELL
$109.52 - $120.96 $136,571 - $150,837
-1,247 Reduced 12.76%
8,523 $968,000
Q4 2023

Feb 01, 2024
BUY
$90.19 - $110.4 $69,085 - $84,566
766 Added 8.51%
9,770 $1.08 Million
Q3 2023

Nov 02, 2023
SELL
$95.53 - $114.62 $46,714 - $56,049
-489 Reduced 5.15%
9,004 $872,000
Q2 2023

Jul 31, 2023
BUY
$100.78 - $112.29 $1,007 - $1,122
10 Added 0.11%
9,493 $1.04 Million
Q1 2023

Apr 27, 2023
BUY
$96.86 - $114.01 $5,617 - $6,612
58 Added 0.62%
9,483 $960,000
Q4 2022

Jan 12, 2023
SELL
$95.06 - $111.52 $26,711 - $31,337
-281 Reduced 2.9%
9,425 $1.04 Million
Q3 2022

Nov 22, 2022
BUY
$96.76 - $112.03 $870 - $1,008
9 Added 0.09%
9,706 $939,000
Q2 2022

Jul 15, 2022
SELL
$102.07 - $123.37 $148,205 - $179,133
-1,452 Reduced 13.02%
9,697 $1.05 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $4,674 - $5,700
-41 Reduced 0.37%
11,149 $1.32 Million
Q4 2021

Feb 07, 2022
SELL
$115.53 - $141.46 $20,217 - $24,755
-175 Reduced 1.54%
11,190 $1.58 Million
Q3 2021

Oct 12, 2021
SELL
$116.66 - $129.06 $23,332 - $25,812
-200 Reduced 1.73%
11,365 $1.34 Million
Q2 2021

Jul 23, 2021
SELL
$105.79 - $124.53 $61,040 - $71,853
-577 Reduced 4.75%
11,565 $1.34 Million
Q1 2021

May 11, 2021
SELL
$108.84 - $128.23 $23,944 - $28,210
-220 Reduced 1.78%
12,142 $1.46 Million
Q4 2020

Feb 10, 2021
SELL
$105.0 - $114.42 $13,230 - $14,416
-126 Reduced 1.01%
12,362 $1.35 Million
Q3 2020

Nov 10, 2020
SELL
$91.64 - $111.29 $9,713 - $11,796
-106 Reduced 0.84%
12,488 $1.36 Million
Q2 2020

Aug 13, 2020
BUY
$76.57 - $98.0 $6,814 - $8,722
89 Added 0.71%
12,594 $1.15 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $51,386 - $75,141
-818 Reduced 6.14%
12,505 $987,000
Q4 2019

Feb 04, 2020
SELL
$78.51 - $87.4 $67,518 - $75,164
-860 Reduced 6.06%
13,323 $1.16 Million
Q3 2019

Nov 06, 2019
BUY
$81.84 - $88.74 $65,226 - $70,725
797 Added 5.95%
14,183 $1.19 Million
Q2 2019

Aug 09, 2019
BUY
$72.88 - $85.0 $9,401 - $10,965
129 Added 0.97%
13,386 $1.13 Million
Q1 2019

May 08, 2019
SELL
$66.22 - $80.06 $42,380 - $51,238
-640 Reduced 4.61%
13,257 $1.06 Million
Q4 2018

Feb 07, 2019
BUY
$65.56 - $74.27 $1,573 - $1,782
24 Added 0.17%
13,897 $1.01 Million
Q3 2018

Nov 09, 2018
SELL
$60.81 - $73.36 $17,026 - $20,540
-280 Reduced 1.98%
13,873 $1.02 Million
Q2 2018

Aug 03, 2018
SELL
$57.57 - $63.54 $136,440 - $150,589
-2,370 Reduced 14.34%
14,153 $863,000
Q1 2018

May 10, 2018
SELL
$56.27 - $63.62 $174,830 - $197,667
-3,107 Reduced 15.83%
16,523 $990,000
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $112,889 - $120,859
-2,103 Reduced 9.68%
19,630 $1.12 Million
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $1.04 Million - $1.17 Million
21,733
21,733 $1.16 Million

Others Institutions Holding ABT

# of Institutions
3,572
Shares Held
1.37B
Call Options Held
9.75M
Put Options Held
8.87M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $222B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Smith Chas P & Associates Pa Cpas Portfolio

Follow Smith Chas P & Associates Pa Cpas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email